William P. Sheridan
2012
In 2012, William P. Sheridan earned a total compensation of $1M as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 41% increase compared to previous year.
Compensation breakdown
| Option Awards | $559,505 |
|---|---|
| Salary | $405,330 |
| Stock Awards | $40,205 |
| Other | $12,500 |
| Total | $1,017,540 |
Sheridan received $559.5K in option awards, accounting for 55% of the total pay in 2012.
Sheridan also received $405.3K in salary, $40.2K in stock awards and $12.5K in other compensation.
Rankings
In 2012, William P. Sheridan's compensation ranked 6,057th out of 11,487 executives tracked by ExecPay. In other words, Sheridan earned more than 47.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,057 out of 11,487 | 47th |
Division Manufacturing | 2,149 out of 4,253 | 50th |
Major group Chemicals And Allied Products | 541 out of 1,198 | 55th |
Industry group Drugs | 368 out of 920 | 60th |
Industry Biological Products, Except Diagnostic Substances | 58 out of 160 | 64th |
Source: SEC filing on April 10, 2015.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2012.
2012
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2012
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2012
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2012
David McCullough
BioCryst Pharmaceuticals